-transparent.png){kind=logo}
Fixed rabies virus strain MNIIVP-74 was grown in Japanese quail embryo cell cultures, concentrated by ultrafiltration and inactivated with beta-propiolactone. The resulting vaccine was markedly antigenic and immunogenic for laboratory animals. Human volunteers injected with 2.0 ml vaccine on days 0, 3, 7, 14, 30 and 90 exhibited more intensive and longer antibody production than those injected daily for 14 days.
Related Publications
M S Bektemirova, and
E R Pille, and
K S Matevosyan, and
F G Nagieva
May 1970,
Lancet (London, England),
M S Bektemirova, and
E R Pille, and
K S Matevosyan, and
F G Nagieva
January 1974,
Voprosy virusologii,
M S Bektemirova, and
E R Pille, and
K S Matevosyan, and
F G Nagieva
January 1980,
Reviews of infectious diseases,
M S Bektemirova, and
E R Pille, and
K S Matevosyan, and
F G Nagieva
January 1973,
Monograph series. World Health Organization,
M S Bektemirova, and
E R Pille, and
K S Matevosyan, and
F G Nagieva
January 1967,
Archiv fur die gesamte Virusforschung,
M S Bektemirova, and
E R Pille, and
K S Matevosyan, and
F G Nagieva
April 1982,
The Japanese journal of experimental medicine,
M S Bektemirova, and
E R Pille, and
K S Matevosyan, and
F G Nagieva
May 1934,
American journal of public health and the nation's health,
M S Bektemirova, and
E R Pille, and
K S Matevosyan, and
F G Nagieva
January 1980,
Voprosy virusologii,
M S Bektemirova, and
E R Pille, and
K S Matevosyan, and
F G Nagieva
April 1946,
American journal of public health and the nation's health,
M S Bektemirova, and
E R Pille, and
K S Matevosyan, and
F G Nagieva
January 1986,
Lancet (London, England),
